116 related articles for article (PubMed ID: 11770797)
21. Antineutrophil cytoplasmic autoantibody-negative Pauci-immune crescentic glomerulonephritis.
Chen M; Yu F; Wang SX; Zou WZ; Zhao MH; Wang HY
J Am Soc Nephrol; 2007 Feb; 18(2):599-605. PubMed ID: 17215440
[TBL] [Abstract][Full Text] [Related]
22. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Yang JJ; Pendergraft WF; Alcorta DA; Nachman PH; Hogan SL; Thomas RP; Sullivan P; Jennette JC; Falk RJ; Preston GA
J Am Soc Nephrol; 2004 Aug; 15(8):2103-14. PubMed ID: 15284296
[TBL] [Abstract][Full Text] [Related]
23. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis.
Lan HY; Yu XQ; Yang N; Nikolic-Paterson DJ; Mu W; Pichler R; Johnson RJ; Atkins RC
Kidney Int; 1998 Jan; 53(1):136-45. PubMed ID: 9453010
[TBL] [Abstract][Full Text] [Related]
24. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
25. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis.
Chen M; Xing GQ; Yu F; Liu G; Zhao MH
Nephrol Dial Transplant; 2009 Apr; 24(4):1247-52. PubMed ID: 18940884
[TBL] [Abstract][Full Text] [Related]
26. Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo.
Tabata H; Honda K; Moriyama T; Itabashi M; Taneda S; Takei T; Tanabe K; Teraoka S; Yamaguchi Y; Oda H; Nitta K
Clin Transplant; 2009 Aug; 23 Suppl 20():49-53. PubMed ID: 19594597
[TBL] [Abstract][Full Text] [Related]
27. [Chronic interstitial pneumonia and crescentic glomerulonephritis associated with perinuclear antineutrophil cytoplasmic antibodies].
Matsuyama W; Koreeda Y; Mizuno K; Mizoguchi A; Iwami F; Osame M
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):555-60. PubMed ID: 9234635
[TBL] [Abstract][Full Text] [Related]
28. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
29. Transcription factor Sp1 expression is upregulated in human glomerulonephritis: correlation with pSmad2/3 and p300 expression and renal injury.
Kassimatis TI; Nomikos A; Giannopoulou I; Lymperopoulos A; Moutzouris DA; Varakis I; Nakopoulou L
Ren Fail; 2010 Jan; 32(2):243-53. PubMed ID: 20199187
[TBL] [Abstract][Full Text] [Related]
30. Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion.
Persy VP; Verstrepen WA; Ysebaert DK; De Greef KE; De Broe ME
Kidney Int; 1999 Aug; 56(2):601-11. PubMed ID: 10432399
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
32. Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN).
Alexopoulos E; Gionanlis L; Papayianni E; Kokolina E; Leontsini M; Memmos D
BMC Nephrol; 2006 Nov; 7():16. PubMed ID: 17078867
[TBL] [Abstract][Full Text] [Related]
33. Histologic analysis of renal leukocyte infiltration in antineutrophil cytoplasmic antibody-associated vasculitis: importance of monocyte and neutrophil infiltration in tissue damage.
Weidner S; Carl M; Riess R; Rupprecht HD
Arthritis Rheum; 2004 Nov; 50(11):3651-7. PubMed ID: 15529388
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.
Terashi T; Aishima S; Taguchi K; Asayama Y; Sugimachi K; Matsuura S; Shimada M; Maehara S; Maehara Y; Tsuneyoshi M
Liver Int; 2004 Feb; 24(1):38-45. PubMed ID: 15101999
[TBL] [Abstract][Full Text] [Related]
35. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
[TBL] [Abstract][Full Text] [Related]
36. IL-1β promotes tubulointerstitial injury in
MPO-ANCA-associated glomerulonephritis
.
Tashiro M; Sasatomi Y; Watanabe R; Watanabe M; Miyake K; Abe Y; Yasuno T; Ito K; Ueki N; Hamauchi A; Noda R; Hisano S; Nakashima H
Clin Nephrol; 2016 Oct; 86(10):190-9. PubMed ID: 27616759
[TBL] [Abstract][Full Text] [Related]
37. Significance of P-selectin expression in human glomerulonephritis.
Li X; Zhou T; Hao C; Dong D; Cheng F; Chen S
Chin Med J (Engl); 1997 Jul; 110(7):512-4. PubMed ID: 9594207
[TBL] [Abstract][Full Text] [Related]
38. Predicting kidney function from renal biopsy. Semiquantitative versus quantitative approach.
Okoń K; Sułowicz W; Smoleński O; Sydor A; Chruściel B; Kirker-Nowak A; Rosiek Z; Sysło K; Stachura J
Pol J Pathol; 2007; 58(2):65-71. PubMed ID: 17715671
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
40. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
Chen M; Yu F; Wang SX; Zou WZ; Zhang Y; Zhao MH; Wang HY
Nephrol Dial Transplant; 2007 Jan; 22(1):139-45. PubMed ID: 16980322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
